Populations- baseret analyse viser, at alder over det undersøgte område (21 – 75 år) ikke signifikant ændrer farmakokinetikken af Caelyx.
Population based analysis demonstrates that age across the range tested (21 – 75 years) does not significantly alter the pharmacokinetics of Caelyx.